BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1690941)

  • 1. Medical aspects on surgery in Graves' disease. Clinical review.
    Karlsson FA; Winsa B; Rastad J; Johansson H
    Acta Chir Scand; 1990 Jan; 156(1):47-51. PubMed ID: 1690941
    [No Abstract]   [Full Text] [Related]  

  • 2. [The pharmacological therapy of Basedow's disease].
    Lazzarin M; Segattini L; Benati F
    Recenti Prog Med; 1993 Oct; 84(10):698-708. PubMed ID: 7694335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The surgical treatment of Graves' disease].
    de Ruijter SH; van Dalen T; Muller AF
    Ned Tijdschr Geneeskd; 2006 Jun; 150(24):1321-5. PubMed ID: 16808361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgery for Graves' disease.
    Black BM
    Mayo Clin Proc; 1972 Dec; 47(12):966-8. PubMed ID: 4117992
    [No Abstract]   [Full Text] [Related]  

  • 5. Remission of Graves' hyperthyroidism treated with methimazole.
    Bolaños F; González-Ortiz M; Durón H; Sánchez C
    Rev Invest Clin; 2002; 54(4):307-10. PubMed ID: 12415954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Basedow's disease: surgery, the choice treatment].
    Chiampo L
    Minerva Endocrinol; 1987; 12(1):49-53. PubMed ID: 2438548
    [No Abstract]   [Full Text] [Related]  

  • 7. Antithyroid drugs--a rational treatment for Graves' disease?
    Leclère J
    Horm Res; 1987; 26(1-4):125-30. PubMed ID: 2439425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease.
    Harper L; Chin L; Daykin J; Allahabadia A; Heward J; Gough SC; Savage CO; Franklyn JA
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):671-5. PubMed ID: 15163328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic and clinical aspects of Graves' disease.
    Feldt-Rasmussen U; Rasmussen AK; Zimmermann-Belsing T; Hartoft-Nielsen ML
    Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 3():S71-4. PubMed ID: 10522809
    [No Abstract]   [Full Text] [Related]  

  • 10. ANCA in Graves' disease--is it antithyroid medication-induced?
    Prakash EB
    J Assoc Physicians India; 2009 Jul; 57():545; author reply 545. PubMed ID: 20329422
    [No Abstract]   [Full Text] [Related]  

  • 11. Graves' disease.
    Rotondi M; Fonte R; Chiovato L
    N Engl J Med; 2008 Sep; 359(13):1407-8; author reply 1409. PubMed ID: 18822458
    [No Abstract]   [Full Text] [Related]  

  • 12. The safety and efficacy of antithyroid drugs.
    Azizi F
    Expert Opin Drug Saf; 2006 Jan; 5(1):107-16. PubMed ID: 16370960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anomalies of cellular immunity in Graves' disease treated by synthetic antithyroid drugs: effects on prognosis].
    Allannic H; Genetet N; Edan G; Merdrignac G; Simon M; Genetet B
    Pathol Biol (Paris); 1987 Dec; 35(10):1333-8. PubMed ID: 2449649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithyroid drugs for the treatment of hyperthyroidism caused by Graves' disease.
    Cooper DS
    Endocrinol Metab Clin North Am; 1998 Mar; 27(1):225-47. PubMed ID: 9534038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Basedow-Graves' disease: operative treatment (author's transl)].
    Röher HD
    Langenbecks Arch Chir; 1978 Nov; 347():137-44. PubMed ID: 83518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Graves-Basedow disease, factors that influence in their relapse].
    Martí Cabané J
    An Med Interna; 2003 Jul; 20(7):388. PubMed ID: 12951976
    [No Abstract]   [Full Text] [Related]  

  • 17. Concentration of TSH-receptor antibodies (TBII) in the sera of patients with immunogenic hyperthyroidism (Graves' disease) receiving antithyroid medication.
    Budihna N; Pavlin K; Porenta M
    Radiobiol Radiother (Berl); 1987; 28(1):101-6. PubMed ID: 2438715
    [No Abstract]   [Full Text] [Related]  

  • 18. Surgical management in Graves' disease.
    Thompson GB
    Panminerva Med; 2002 Dec; 44(4):287-93. PubMed ID: 12434111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recurrence rate following thyrostatic therapy of patients with hyperthyroidism and diffuse goiter (Graves' disease). Relation to the concentration of inorganic iodine in the plasma].
    Hansen PE
    Ugeskr Laeger; 1983 Mar; 145(13):980-2. PubMed ID: 6190284
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antithyrotropin receptor antibodies in a series of Basedow's disease].
    Vidal E; Antoine E; Nadalon S; Cevallos R; Bournaud E; Vandroux JC; Bordessoule D; Loustaud V; Weinbreck P; Liozon F
    Ann Med Interne (Paris); 1988; 139(5):331-5. PubMed ID: 2462393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.